scispace - formally typeset
M

Matthew J. Grainge

Researcher at University of Nottingham

Publications -  161
Citations -  12236

Matthew J. Grainge is an academic researcher from University of Nottingham. The author has contributed to research in topics: Population & Cohort study. The author has an hindex of 47, co-authored 147 publications receiving 10081 citations. Previous affiliations of Matthew J. Grainge include University of Leicester & Nottingham University Hospitals NHS Trust.

Papers
More filters
Journal ArticleDOI

Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

TL;DR: This study identifies the presence of variations in global levels of histone marks in different grades, morphologic types, and phenotype classes of invasive breast cancer and shows that these differences have clinical significance.
Journal ArticleDOI

The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies.

TL;DR: There are worldwide differences in the incidence and prevalence of SLE that vary with sex, age, ethnicity and time and further study of genetic and environmental risk factors may explain the reasons for these differences.
Journal ArticleDOI

Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials

TL;DR: Aspirin is effective for the prevention of colorectal adenomas in individuals with a history of these lesions and no statistically significant effect modification for any of the baseline factors studied.
Journal ArticleDOI

Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis

TL;DR: This study summarizes the existing literature to determine the risk of venous thromboembolism in high- and average-risk groups of patients with different cancers.
Journal ArticleDOI

Aspirin and folic acid for the prevention of recurrent colorectal adenomas

TL;DR: Aspirin but not folate use was found to reduce the risk of colorectal adenoma recurrence, with evidence that aspirin could have a significant role in preventing the development of advanced lesions.